Boston’s biotech industry raised more than $1.5 billion in venture capital funding in May, BostInno reported. Among the handful of startups to benefit from funding include Amwell, a Boston-based telemedicine company, that raised $194 million in Series C funding as some doctors treat patients by...
Two initial public offerings (IPOs) are testing investors’ appetites amid the coronavirus pandemic, according to statements from Zentalis Pharmaceuticals and WiMi Hologram Cloud. Zentalis Pharmaceuticals, a biotech group based in San Diego, California, raised about $165 million. Augmented reality (AR) startup WiMi Hologram Cloud, based...
Companies that want to go public during the first part of the year are hampered by a key roadblock: The month-long government shutdown has also shuttered the Securities and Exchange Commission (SEC), which usually works with companies for months before approving an IPO. Now, some...
Use cases are growing with blockchain, and while the headlines may focus on large-scale government initiatives and where distributed ledger technology (DLT) might be headed, the fact remains that smaller projects are gaining traction. Looking on a case-by-case basis, state initiatives (or local ones outside...
June 01, 2020
Boston’s biotech industry raised more than $1.5 billion in venture capital funding in May, BostInno reported. Among the handful of startups to benefit from funding include Amwell, a Boston-based telemedicine company, that raised $194 million in Series C funding as some doctors treat patients by video messaging; Atea Pharmaceuticals, a Boston-based developer of therapies for […]
April 05, 2020
Two initial public offerings (IPOs) are testing investors’ appetites amid the coronavirus pandemic, according to statements from Zentalis Pharmaceuticals and WiMi Hologram Cloud. Zentalis Pharmaceuticals, a biotech group based in...
January 21, 2019
Companies that want to go public during the first part of the year are hampered by a key roadblock: The month-long government shutdown has also shuttered the Securities and Exchange...
